| Literature DB >> 24875058 |
Marcus R Streit1, Stefan Weiss, Franziska Andreas, Thomas Bruckner, Tilman Walker, J Philippe Kretzer, Volker Ewerbeck, Christian Merle.
Abstract
BACKGROUND ANDEntities:
Mesh:
Substances:
Year: 2014 PMID: 24875058 PMCID: PMC4105767 DOI: 10.3109/17453674.2014.925351
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Figure 1.The uncemented Allofit acetabular component with macrotextured surface, hemispherical periphery, and a flattened polar region.
Demographics and distribution of hips
| Demographics | Male | Female | Total |
|---|---|---|---|
| Mean age (SD) | 50 (8.7) | 51 (6.3) | 51 (7.8) |
| No. of hips (%) | 74 (61%) | 47 (39%) | 121 (100%) |
| Mean BMI (SD) | 28 (4.4) | 26 (4.6) | 27 (4.5) |
| Right:left | 40:34 | 22:25 | 62:59 |
Details of the diagnosis for the 121 hips
| Diagnosis | No. of hips (%) |
|---|---|
| Osteoarthrosis | 77 (64) |
| CDH | 21 (17) |
| Avascular necrosis | 13 (11) |
| Posttraumatic OA | 3 (2) |
| Rheumatoid arthritis | 2 (2) |
| Other | 5 (4) |
| Giant-cell tumor | 1 (1) |
| Osteochondrosarcoma | 1 (1) |
| SCFE | 1 (1) |
| Perthes’ | 1 (1) |
| Coxitis | 1 (1) |
CDH: congenital dysplasia of the hip;
OA: osteoarthrosis;
SCFE: slipped capital femoral epiphysis.
Figure 2.Distribution of hips at final follow-up.
Figure 3.Kaplan-Meier survivorship curve and 95% CI with acetabular revision for any reason as endpoint. Eleven-year survival was estimated at 97.5% (95% CI: 92.4–99.2; 32 hips at risk).
Figure 4.Kaplan-Meier survivorship curve and 95% CI with acetabular revision for aseptic loosening as endpoint. Eleven-year survival was estimated at 99.2% (95% CI: 94.2–99.9; 32 hips at risk).
Figure 5.Comparison of Kaplan-Meier survivorship curves with acetabular revision for any reason as endpoint for hips with 28-mm Metasul articulation (n = 86) vs. ceramic-on-polyethylene articulation (n = 34) (log-rank test, p = 0.86)
Figure 6.Comparison of Kaplan-Meier survivorship curves with acetabular revision for any reason as endpoint for patients aged ≤ 50 at the time of surgery (n = 45) vs. patients aged > 50 (n = 76) (log-rank test, p = 0.91).
Figure 7.Anteroposterior radiograph of the left hip in a 44-year-old woman with CDH at 12 years after THA.
Results of uncemented acetabular components with 10- or more-year follow-up in young patients. The inclusion criteria were (1) patients who were 60 years of age or younger at the time of surgery, and (2) patients with a minimum duration of follow-up of 10 years
| A | B | C | D | E | F | G | H | I | J |
|---|---|---|---|---|---|---|---|---|---|
| Duffy et al. |
| Harris-Galante I | metal-poly | 84 | 10 | 38 | 84.5 at 10 y | 98.7 at 10 y | 10 |
| Utting et al. |
| Harris-Galante I | metal-poly | 70 | 14 | 40 | 84 at 14 y | – | 19 |
| Akbar et al. |
| DSP-CUP | ceramic-poly | 72 | 14 | 35 | 86 at 14 y | – | – |
| Migaud et al. |
| Armor | 28-mm Metasul | 39 | 13 | 40 | 100 at 12 y | 100 at 12 y | 3 |
| Hwang et al. |
| Wagner | 28-mm Metasul | 78 | 12 | 40 | 98.7 at 12 y | – | 2 |
| Kim et al. |
| Duraloc | metal-poly | 532 | 15 | 39.3 | 82 at 15 y | 100 at 15 y | 20 |
| Current study | 2014 | Allofit | 28-mm Metasul | 86 | 11 | 50 | 97.6 at 11 y | 98.8 at 11 y | 0 |
| ceramic-poly | 34 | 11 | 54 | 97.0 at 11 y | 100 at 11 y | 0 |
No longer available for clinical use.
A Study
B Year
C Cup
D Articulation
E No. of hips
F Mean follow-up (years)
G Mean age at surgery (years)
H Survivorship, all cup revisions (incl. liner revision, %)
I Survivorship, aseptic cup loosening (%)
J Periacetabular osteolysis (%)